Feedback / Questions
Undisclosed pan-EGFR degrader - AstraZeneca
https://www.prnewswire.com/news-releases/pinetree-therapeutics-announces-exclusive-option-and-global-license-agreement-for-preclinical-egfr-degrader-candidate-with-astrazeneca-302204218.html
 
Jul 23, 2024
 
SHARE THIS
  • Print
  • Email
  • More sharing
    Reddit
    StumbleUpon
    Delicious